Voloridge Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-79,071
| Closed | -$1.05M | – | 1353 |
|
|
2024
Q4 | $1.05M | Buy |
+79,071
| New | +$1.05M | ﹤0.01% | 1034 |
|
|
2022
Q4 | – | Sell |
-21,563
| Closed | -$518K | – | 1626 |
|
|
2022
Q3 | $518K | Buy |
21,563
+11,141
| +107% | +$268K | ﹤0.01% | 1259 |
|
|
2022
Q2 | $201K | Sell |
10,422
-110,609
| -91% | -$2.13M | ﹤0.01% | 1381 |
|
|
2022
Q1 | $2.1M | Buy |
121,031
+107,202
| +775% | +$1.86M | 0.01% | 933 |
|
|
2021
Q4 | $303K | Buy |
+13,829
| New | +$303K | ﹤0.01% | 1471 |
|